Clinical trial
Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder
NCT00391001 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder
- Lead sponsor
- Cambridge Health Alliance
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 28, 2006
- Completion date
- August 31, 2007
- Enrollment
- 4 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.